We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

GENinCode plc (GENI) ORD GBP0.01

Sell:1.80p Buy:2.10p 0 Change: 0.25p (11.36%)
Market closed |  Prices as at close on 9 January 2026 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1.80p
Buy:2.10p
Change: 0.25p (11.36%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 9 January 2026 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1.80p
Buy:2.10p
Change: 0.25p (11.36%)
Market closed |  Prices as at close on 9 January 2026 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Share news, reports & tips

  • GENinCode lowers outlook, shares slide

    30 September 2025 07:17

    (Sharecast News) - GENinCode warned on revenues on Tuesday, sending shares in the AIM-listed predictive genetics specialist sliding.

  • GENinCode H1 revenues grow, losses unchanged YOY

    26 August 2025 10:35

    (Sharecast News) - Predictive genetics firm GENinCode said on Tuesday that interim losses were unchanged year-on-year but noted that it had seen "continued strengthening of business" in the six...

  • GENinCode enters collaboration with US Family Heart Foundation

    20 September 2024 14:22

    (Sharecast News) - GENinCode announced a collaboration with the Family Heart Foundation, UT Southwestern, and other partners on Friday, to implement its LIPID inCode genetic test for diagnosing familial...

  • GENinCode inks partnership with DC's MedStar Health

    19 July 2023 10:42

    (Sharecast News) - Predictive generics specialist GENinCode announced a collaboration with MedStar Health on Wednesday - a prominent 10-hospital health system in the Washington, DC area of the United States.

Company announcements Announcements


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.

© Digital Look Ltd 1998-2026. All rights reserved.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.